Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of Illness
Covid-19 features a delayed onset of critical illness occurring approximately one week from the beginning of symptoms, which corresponds to the bridging of innate and adaptive immunity. We reasoned that the immune events occurring at the turning point of disease might mark the direction toward patho...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2020.580987/full |
id |
doaj-e853cf9a95884293b1c10cb7a2f23d8c |
---|---|
record_format |
Article |
spelling |
doaj-e853cf9a95884293b1c10cb7a2f23d8c2020-11-25T03:08:01ZengFrontiers Media S.A.Frontiers in Immunology1664-32242020-10-011110.3389/fimmu.2020.580987580987Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of IllnessCamilla Tincati0E. Stefania Cannizzo1Mauro Giacomelli2Raffaele Badolato3Antonella d’Arminio Monforte4Giulia Marchetti5Department of Health Sciences, Clinic of Infectious Diseases, ASST Santi Paolo e Carlo, University of Milan, Milan, ItalyDepartment of Health Sciences, Clinic of Infectious Diseases, ASST Santi Paolo e Carlo, University of Milan, Milan, ItalyDipartimento di Scienze Cliniche e Sperimentali, Università degli Studi di Brescia, ASST Spedali Civili and A. Nocivelli Institute of Molecular Medicine, c/o Spedali Civili, Brescia, ItalyDipartimento di Scienze Cliniche e Sperimentali, Università degli Studi di Brescia, ASST Spedali Civili and A. Nocivelli Institute of Molecular Medicine, c/o Spedali Civili, Brescia, ItalyDepartment of Health Sciences, Clinic of Infectious Diseases, ASST Santi Paolo e Carlo, University of Milan, Milan, ItalyDepartment of Health Sciences, Clinic of Infectious Diseases, ASST Santi Paolo e Carlo, University of Milan, Milan, ItalyCovid-19 features a delayed onset of critical illness occurring approximately one week from the beginning of symptoms, which corresponds to the bridging of innate and adaptive immunity. We reasoned that the immune events occurring at the turning point of disease might mark the direction toward pathogenic versus protective inflammatory responses. Subjects with either severe (s; PaO2/FiO2 ratio <200) or mild (m; PaO2/FiO2 ratio>300) Covid-19 were enrolled. A range of chemokines and cytokines as well as reactive oxygen species (ROS) were measured in plasma. Dendritic and NK cell frequency, monocyte and B-/T-cell phenotype and SARS-CoV-2-specific T-cell responses were assessed in PBMC. Twenty mCovid-19 and 20 sCovid-19 individuals were studied. sCovid-19 patients displayed higher non-classical monocytes, plasma chemokines (CXCL8, CXCL9, CXCL10), cytokines (IL-6, IL-10), and ROS versus mCovid-19. sCovid-19 also showed significantly increased activated CD38+HLA-DR+ T-lymphocyte, and granzyme-B+/perforin+ pro-cytolytic T-cells. All Covid-19 patients showed SARS-CoV-2 specific-T-cell response with a predominance of Th1 bi- or trifunctional IFN-γ/IL-2/TNF-α-expressing CD4+, while no difference according to disease severity was observed. Severe Covid-19 features heightened circulating IFN-inducible chemokines and activated pro-cytolytic Th1 cell phenotype in the second week of illness, yet SARS-CoV-2-specific responses are similar to that of mild illness. Altogether, our observations suggest Th1 polarization coupled to higher cytolytic profile in sCovid-19 as correlate of disease pathogenesis and as potential targets to be investigated in the roadmap to therapy and vaccine development.https://www.frontiersin.org/articles/10.3389/fimmu.2020.580987/fullCovid-19SARS-CoV-2immunityS/M/N protein-reactive T-cellsimmunopathology |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Camilla Tincati E. Stefania Cannizzo Mauro Giacomelli Raffaele Badolato Antonella d’Arminio Monforte Giulia Marchetti |
spellingShingle |
Camilla Tincati E. Stefania Cannizzo Mauro Giacomelli Raffaele Badolato Antonella d’Arminio Monforte Giulia Marchetti Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of Illness Frontiers in Immunology Covid-19 SARS-CoV-2 immunity S/M/N protein-reactive T-cells immunopathology |
author_facet |
Camilla Tincati E. Stefania Cannizzo Mauro Giacomelli Raffaele Badolato Antonella d’Arminio Monforte Giulia Marchetti |
author_sort |
Camilla Tincati |
title |
Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of Illness |
title_short |
Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of Illness |
title_full |
Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of Illness |
title_fullStr |
Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of Illness |
title_full_unstemmed |
Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of Illness |
title_sort |
heightened circulating interferon-inducible chemokines, and activated pro-cytolytic th1-cell phenotype features covid-19 aggravation in the second week of illness |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Immunology |
issn |
1664-3224 |
publishDate |
2020-10-01 |
description |
Covid-19 features a delayed onset of critical illness occurring approximately one week from the beginning of symptoms, which corresponds to the bridging of innate and adaptive immunity. We reasoned that the immune events occurring at the turning point of disease might mark the direction toward pathogenic versus protective inflammatory responses. Subjects with either severe (s; PaO2/FiO2 ratio <200) or mild (m; PaO2/FiO2 ratio>300) Covid-19 were enrolled. A range of chemokines and cytokines as well as reactive oxygen species (ROS) were measured in plasma. Dendritic and NK cell frequency, monocyte and B-/T-cell phenotype and SARS-CoV-2-specific T-cell responses were assessed in PBMC. Twenty mCovid-19 and 20 sCovid-19 individuals were studied. sCovid-19 patients displayed higher non-classical monocytes, plasma chemokines (CXCL8, CXCL9, CXCL10), cytokines (IL-6, IL-10), and ROS versus mCovid-19. sCovid-19 also showed significantly increased activated CD38+HLA-DR+ T-lymphocyte, and granzyme-B+/perforin+ pro-cytolytic T-cells. All Covid-19 patients showed SARS-CoV-2 specific-T-cell response with a predominance of Th1 bi- or trifunctional IFN-γ/IL-2/TNF-α-expressing CD4+, while no difference according to disease severity was observed. Severe Covid-19 features heightened circulating IFN-inducible chemokines and activated pro-cytolytic Th1 cell phenotype in the second week of illness, yet SARS-CoV-2-specific responses are similar to that of mild illness. Altogether, our observations suggest Th1 polarization coupled to higher cytolytic profile in sCovid-19 as correlate of disease pathogenesis and as potential targets to be investigated in the roadmap to therapy and vaccine development. |
topic |
Covid-19 SARS-CoV-2 immunity S/M/N protein-reactive T-cells immunopathology |
url |
https://www.frontiersin.org/articles/10.3389/fimmu.2020.580987/full |
work_keys_str_mv |
AT camillatincati heightenedcirculatinginterferoninduciblechemokinesandactivatedprocytolyticth1cellphenotypefeaturescovid19aggravationinthesecondweekofillness AT estefaniacannizzo heightenedcirculatinginterferoninduciblechemokinesandactivatedprocytolyticth1cellphenotypefeaturescovid19aggravationinthesecondweekofillness AT maurogiacomelli heightenedcirculatinginterferoninduciblechemokinesandactivatedprocytolyticth1cellphenotypefeaturescovid19aggravationinthesecondweekofillness AT raffaelebadolato heightenedcirculatinginterferoninduciblechemokinesandactivatedprocytolyticth1cellphenotypefeaturescovid19aggravationinthesecondweekofillness AT antonelladarminiomonforte heightenedcirculatinginterferoninduciblechemokinesandactivatedprocytolyticth1cellphenotypefeaturescovid19aggravationinthesecondweekofillness AT giuliamarchetti heightenedcirculatinginterferoninduciblechemokinesandactivatedprocytolyticth1cellphenotypefeaturescovid19aggravationinthesecondweekofillness |
_version_ |
1724667721551970304 |